President Donald Trump said his tariffs spurred Novartis AG to expand its US manufacturing footprint, following a meeting with the Swiss drugmaker’s chief executive Vas Narasimhan at the White House ...

In this week’s edition of InnovationRx, we look at the startup that wants to treat Alzheimer’s with microrobots, medical ...

Novartis has settled a suit by Henrietta Lacks' estate alleging the pharmaceutical giant unjustly profited off cells were ...

So, can Novartis help investors build a millionaire retirement portfolio? Under the right circumstances, yes. The stock can provide stability, reliability, and steady income to a well-diversified ...

NVS wins CHMP backing for remibrutinib in chronic spontaneous urticaria, bringing its oral BTK inhibitor closer to EU approval.

The family of Henrietta Lacks settles lawsuit with Novartis over use of her cells, marking a turning point in fight for ...

Novartis has a solid portfolio of drugs and a pipeline that should keep the business humming.

Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when ...

Novartis, continuing its string of expansions for radioligand therapy manufacturing, announced February 25 that it would ...

Guided by immigrant roots, public‑health purpose and a belief in “staying in the ring,” Novartis CEO Vas Narasimhan reflects ...

A new biotech has taken flight as a result of Novartis’ red-hot $12 billion acquisition of muscular dystrophy specialist Avidity Biosciences. | A new biotech has risen from the ashes of Novartis’ ...

The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.